Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Anji, Athersys, Belief Biomed, China Oncology Focus, Cstone, Healios, Imugene, Prota, Recce, Regencell, Sorrento, Synairgen, Urovant Sciences.